E-DRUG Archives (by date)

• Thread Index

November 30, 2004
• [e-drug] two generic ARVs back on WHO Prequalification list
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Advanced Purchase Contracts and Other Ideas
  • From: "Spring Gombe" <spring@haiweb.org>
November 29, 2004
• [e-drug] Patent Legislation Analysis in Latin America / Caribbean
  • From: "Gabriela Costa Chaves" <gabi@ensp.fiocruz.br>
• [e-drug] Rescuing malaria treatment, or not?
  • From: "E-Drug" <e-drug@healthnet.org>
November 27, 2004
• [e-drug] Nimesulide (final)
  • From: "Olutayo Adetokunbo" <oamoronkeji@yahoo.com>
• [e-drug] Vioxx, the implosion of Merck, and aftershocks at the FDA
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Europe's health priorities for the world
  • From: "E-Drug" <e-drug@healthnet.org>
November 26, 2004
• [e-drug] Co-trimoxazole prophylaxis for all? (2)
  • From: "Eurek Ranjit" <dhyan@wlink.com.np>
• [e-drug] MSF: Guatemala Repeals Law That Restricted Access to Medicines
  • From: "E-Drug" <e-drug@healthnet.org>
November 25, 2004
• [e-drug] RFI: Nimesulide ADRs? (10)
  • From: "miriam" <miriam@mcdf.sld.cu>
• [e-drug] Rofecoxib ADRs
  • From: pals@who.int
• [e-drug] Revolving Drug Funds at village level (2)
  • From: tatah@who.int
November 24, 2004
• [e-drug] Pharmaceutical industry funding of clinical research
  • From: "Joel Lexchin" <joel.lexchin@utoronto.ca>
• [e-drug] Revolving Drug Funds at village level
  • From: "Bigdeli, Ms Maryam (LAO)" <bigdelim@lao.wpro.who.int>
• [e-drug] Postmarketing Surveillance - Lack of Vigilance, Lack of Trust
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] new professional search tool scholar.google.com
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] RFI: Nimesulide ADRs? (9)
  • From: "Chandra Gulhati" <seeemgee@yahoo.co.uk>
November 23, 2004
• [e-drug] RFI: Nimesulide ADRs? (8)
  • From: "Dr.L.Offerhaus" <offerhausl@euronet.nl>
• [e-drug] Scaling up access to ARVs with African community based organizations
  • From: c.prunier@sidaction.org
• [e-drug] RFI: Nimesulide ADRs? (7)
  • From: "rahmansz" <rahmansz@sancharnet.in>
• [e-drug] cotrimoxazole prophylaxis in children
  • From: "Wilbert Bannenberg" <wjb@wxs.nl>
November 22, 2004
• [e-drug] RFI: Nimesulide ADRs? (6)
  • From: "Dr P.H. Rao" <drphrao@asci.org.in>
• [e-drug] RFI: Nimesulide ADRs? (5)
  • From: "Dr.Anupam Aggarwal" <dr.anupam@vsnl.com>
• [e-drug] Wording of Papers, Use of Statistics (3)
  • From: "Klara Tisocki" <ktisocki@yahoo.ie>
• [e-drug] celebrex in Turkey
  • From: "F.CANKAT TULUNAY" <tulunay@dialup.ankara.edu.tr>
• [e-drug] RFI: Nimesulide ADRs? (4)
  • From: "Chandra Gulhati" <seeemgee@yahoo.co.uk>
• [e-drug] RFI: Nimesulide ADRs? (3)
  • From: "Chandra Gulhati" <seeemgee@yahoo.co.uk>
• [e-drug] QU4RAD e-conference: are there alternatives to patents?
  • From: "Amorie Glenn J. de Guzman" <adeguzman@ateneo.edu>
November 21, 2004
• [e-drug] RFI: Nimesulide ADRs? (2)
  • From: "Rakesh Chaurasia" <chaurasiarakesh@macleodspharma.com>
• [e-drug] Wording of Papers, Use of Statistics (2)
  • From: "Dr.Leo Offerhaus" <offerhausl@euronet.nl>
• [e-drug] Attending to a sick industry? (2)
  • From: "Kibumba George" <kibumba@yahoo.com>
• [e-drug] Wording of Papers, Use of Statistics
  • From: "Kibumba George" <kibumba@yahoo.com>
November 20, 2004
• [e-drug] Revisiting phenobarbital for epilepsy
  • From: "Wilbert Bannenberg" <wjb@wxs.nl>
• [e-drug] Dorette Corbey (MEP) on R&D for neglected diseases
  • From: "Wilbert Bannenberg" <wjb@wxs.nl>
• [e-drug] RFI: Nimesulide ADRs?
  • From: "Olutayo Adetokunbo" <oamoronkeji@yahoo.com>
• [e-drug] Regulating pharmaceuticals in Europe
  • From: "Wilbert Bannenberg" <wjb@wxs.nl>
• [e-drug] Attending to a sick industry?
  • From: "Wilbert Bannenberg" <wjb@wxs.nl>
• [e-drug] Free WHO Medicines Bookshelf CD-ROM
  • From: "WHO/EDM Documentation Centre" <edmdoccentre@who.int>
November 19, 2004
• [e-drug] Priority Medicines for Europe and the World - conclusions
  • From: "Wilbert Bannenberg" <wjb@wxs.nl>
• [e-drug] New vaccines to fight killer rotavirus
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] WHO's TB control strategy said to be insufficient
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Insomnia treatments harmful and not effective
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Hetero withdraws 6 ARVs from WHO PQ list
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] The important world of drug prequalification (2)
  • From: JBRusso@aol.com
• [e-drug] Shortage of ACTs and other pharmaceuticals (4)
  • From: "Oliver Hazemba" <ohazemba@zamnet.zm>
• [e-drug] The important world of drug prequalification
  • From: "Nathan Ford" <nathan.ford@london.msf.org>
• [e-drug] Economist on ACT shortages
  • From: "Nathan Ford" <nathan.ford@london.msf.org>
• [e-drug] Global Fund Board Agrees to 5th Round of Proposals
  • From: "Wilbert Bannenberg" <wjb@wxs.nl>
• [e-drug] Co-trimoxazole prophylaxis for all?
  • From: "Ron Wehrens - Phasuma" <r.wehrens@phasuma.com>
November 18, 2004
• [e-drug] Flu Vaccine
  • From: "Warren Kaplan" <wak@bu.edu>
• [e-drug] Priority Medicines for Europe and the World (2)
  • From: "Christophe Kopp" <Christophe.Kopp@wanadoo.fr>
• [e-drug] Global Fund discusses procurement rules
  • From: "Carmen Perez" <carmen.perez@paris.msf.org>
• [e-drug] WHO Priority medicines report
  • From: "E-Drug" <e-drug@healthnet.org>
November 17, 2004
• [e-drug] proposed WHO EML changes 2005 (2)
  • From: "Cecile Godfroid" <cgodfroid@unicef.org>
• [e-drug] Mexico Summit on Health Research -- press coverage
  • From: "Sean Healey" <Sean.HEALY@geneva.msf.org>
• [e-drug] Rofecoxib (Vioxx) withdrawal
  • From: "Ciprian Jauca" <jauca@ti.ubc.ca>
• [e-drug] Unaffordable drug prices cause hypertension noncompliance (2)
  • From: "Murtada Sesay" <msesay@unicef.org>
November 16, 2004
• [e-drug] MSF: R&D System Failing to Meet Health Needs of Developing Countries
  • From: "Rachel COHEN" <Rachel.COHEN@newyork.msf.org>
• [e-drug] therapeutic equivalence of different dosage forms? (7)
  • From: "claudia vacca" <cvaquis@hotmail.com>
• [e-drug] Unaffordable drug prices cause hypertension non-compliance in Ghana
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] please be a little moderate....(5)
  • From: "Chris W. Green" <chrisg@rad.net.id>
• [e-drug] therapeutic equivalence of different dosage forms? (6)
  • From: "Rakesh Chaurasia" <chaurasiarakesh@macleodspharma.com>
• [e-drug] please be a little moderate.... (4)
  • From: "Chandra Gulhati" <seeemgee@yahoo.co.uk>
November 15, 2004
• [e-drug] please be a little moderate.... (3)
  • From: "Sarah Sellers" <ssellers@jhsph.edu>
• [e-drug] BMJ on ARV rollout, Malawi experience
  • From: "Wilbert Bannenberg" <wjb@wxs.nl>
• [e-drug] shortage of ACTs and other pharmaceuticals (3)
  • From: "Abdelkrim Smine" <ays@usp.org>
• [e-drug] please be a little moderate.... (2)
  • From: "Valeria Frighi" <valeria.frighi@doctors.org.uk>
• [e-drug] Teaching pharmacy and medical students about promotion(4)
  • From: "Kevin Outterson" <Kevin.Outterson@mail.wvu.edu>
• [e-drug] The concept of essential medicines: lessons for rich countries
  • From: "E-Drug" <e-drug@healthnet.org>
November 14, 2004
• [e-drug] Teaching pharmacy and medical students about promotion(3)
  • From: "Stevan Gressitt" <gressitt@uninets.net>
• [e-drug] please be a little moderate....
  • From: "Bernhard Edgren" <be@triuno.com>
• [e-drug] NY Times: Do New Drugs Always Have to Cost So Much?
  • From: "Nathan Ford" <nathan.ford@london.msf.org>
• [e-drug] shortage of ACTs and other pharmaceuticals (2)
  • From: "Murtada Sesay" <msesay@unicef.org>
November 13, 2004
• [e-drug] shortage of ACTs and other pharmaceuticals
  • From: "Libby Levison" <libby@theplateau.com>
• [e-drug] Qu4RAD conference: Are there alternatives to patents?
  • From: "reinhard huss" <reinhard.huss@urz.uni-heidelberg.de>
November 12, 2004
• [e-drug] Shortage of ACT for malaria (5)
  • From: "Judith Mandelbaum-Schmid" <schmidj@who.int>
November 11, 2004
• [e-drug] promotion material produced by the industry (2)
  • From: "Judith Mackson" <jmackson@nps.org.au>
• [e-drug] Shake-up for UK drug regulatory authority
  • From: "Libby Levison" <libby@theplateau.com>
• [e-drug] DNDI: More resources needed for neglected diseases
  • From: "Jaya Banerji" <jbanerji@dndi.org>
• [e-drug] celecoxib warning in Turkey
  • From: "F.CANKAT TULUNAY" <tulunay@dialup.ankara.edu.tr>
November 10, 2004
• [e-drug] WHO/AMDS Information Library
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] WHO Expert Committee on Specifications for Pharmaceutical Preparations
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] unethical marketing of prescription drugs
  • From: Vera Hassner Sharav <veracare@ahrp.org>
• [e-drug] Shortage of ACT for malaria (4)
  • From: Sean.HEALY@geneva.msf.org
• [e-drug] shortage of ACT for malaria (3)
  • From: "Cheri Grace" <CGrace@london.edu>
• [e-drug] Ranbaxy withdraws all generic ARVs from WHO Prequalification(3)
  • From: "Francisco Rossi" <francisco_rossi@hotmail.com>
• [e-drug] Ranbaxy withdraws all generic ARVs from WHO Prequalification (2)
  • From: "Warren Kaplan" <wak22@comcast.net>
• [e-drug] therapeutic equivalence of different dosage forms? (5)
  • From: "Peter Mol" <p.mol@med.rug.nl>
• [e-drug] Ranbaxy withdraws all generic ARVs from WHO Prequalification (2)
  • From: "E-drug" <e-drug@healthnet.org>
November 09, 2004
• [e-drug] shortage of ACT for malaria (2)
  • From: "Christine Sadia" <csa@lutheranworld.org>
• [e-drug] How to detect misleading claims in clinical research reports
  • From: "E-drug" <e-drug@healthnet.org>
• [e-drug] Race-based medicine
  • From: "Andy Gray" <graya1@ukzn.ac.za>
• [e-drug] IFPMA reorganising after criticism
  • From: "E-drug" <e-drug@healthnet.org>
• [e-drug] Ranbaxy withdraws all generic ARVs from WHO Prequalification
  • From: "E-drug" <e-drug@healthnet.org>
• [e-drug] shortage of artemisinin-based combination therapy for malaria
  • From: "E-drug" <e-drug@healthnet.org>
• [e-drug] therapeutic equivalence of different dosage forms? (4)
  • From: "Murtada Sesay" <msesay@unicef.org>
• [e-drug] Teaching pharmacy and medical students about promotion (2)
  • From: "Emmanuel Alphonce" <emmaa_25551@yahoo.com>
• [e-drug] therapeutic equivalence of different dosage forms? (3)
  • From: "romaci" <romaci@takas.lt>
November 08, 2004
• [e-drug] promotion material produced by the industry
  • From: "saeed farooq" <sfarooqlrh@yahoo.com>
• [e-drug] therapeutic equivalence of different dosage forms? (2)
  • From: "Nadeem Irfan Bukhari" <nadeemi@imu.edu.my>
• [e-drug] Regulating health: global pharmaceuticals in transition
  • From: "Ken Harvey" <k.harvey@latrobe.edu.au>
• [e-drug] Electronic Prescribing
  • From: "Mark Duman" <mark_duman@yahoo.co.uk>
• [e-drug] therapeutic equivalence of different dosage forms?
  • From: "r ancuceanu" <ancuceanu77@ifrance.com>
• [e-drug] Global public private partnerships: new publication
  • From: "PatientView " <info@patient-view.com>
November 05, 2004
• [e-drug] Vacancies for pharmacists in Tajikistan and in Cambodia
  • From: "Martins" <i.martins@psf-ci.org>
• [e-drug] Can we document experiences with PEPFAR please? (8)
  • From: "Albert Petersen" <petersen.amh@difaem.de>
November 04, 2004
• [e-drug] 18 Nov The Hague: Setting priorities, missing the point
  • From: "Spring Gombe" <spring@haiweb.org>
November 03, 2004
• [e-drug] WHO workshop on IP rights and vaccines in developing countries
  • From: "Miloud Kaddar" <kaddarm@who.int>
• [e-drug] Teaching pharmacy and medical students about promotion
  • From: "Richard Laing" <laingr@who.int>
• [e-drug] Paediatric AIDS is a neglected disease
  • From: "Sean Healy" <Sean.HEALY@geneva.msf.org>
November 02, 2004
• [e-drug] Cost/efficient procurement (2)
  • From: "Oliver Hazemba" <ohazemba@zamnet.zm>
• [e-drug] MSF: Lack of AIDS Drugs for Children a Matter of Life and Death
  • From: Sean.HEALY@geneva.msf.org
November 01, 2004
• [e-drug] rofecoxib ban in India (6)
  • From: "Eurek Ranjit" <dhyan@wlink.com.np>
• [e-drug] Update your WHO/EDM Bookshelf
  • From: "Hans Hogerzeil" <hogerzeilh@who.int>